BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/28/2026 10:36:03 AM | Browse: 3 | Download: 0
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Delirium in the oncology intensive care unit: Risk, recognition, and recovery strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Prashant Sirohiya, Prateek Maurya, Nishkarsh Gupta, Saurabh Vig, Balbir Kumar, Brajesh Kumar Ratre, Raghav Gupta, Shweta Bhopale and Anuja Pandit |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Prashant Sirohiya, Assistant Professor, Department of Onco-Anaesthesia and Palliative Medicine, National Cancer Institute, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, Delhi, India. sirohiyaprashant@gmail.com |
| Key Words |
Delirium; Oncology intensive care unit; Cancer critical care; Cognitive dysfunction; Neurological complications; Palliative care; Intensive care unit outcomes; Chemotherapy neurotoxicity; Post-intensive care syndrome; Cancer survivorship |
| Core Tip |
Delirium affects up to 88% of critically ill cancer patients, increasing intensive care units (ICU) mortality tenfold and making post-discharge treatment discontinuation four times more likely. This review introduces the “double burden” of ICU delirium superimposed on chemotherapy-related cognitive impairment, creating unique survivorship challenges. Cancer-specific vulnerabilities include chemotherapy neurotoxicity, central nervous system malignancy, and chimeric antigen receptor T-associated neurotoxicity. Evidence favors non-pharmacologic prevention, with early mobilization reducing delirium by 47%. Delirium thus extends beyond transient confusion to a key determinant of cancer survivorship, potentially transforming ICU admission into a treatment-limiting event. |
| Citation |
Sirohiya P, Maurya P, Gupta N, Vig S, Kumar B, Ratre BK, Gupta R, Bhopale S, Pandit A. Delirium in the oncology intensive care unit: Risk, recognition, and recovery strategies. World J Crit Care Med 2026; In press |
 |
Received |
|
2025-09-28 08:31 |
 |
Peer-Review Started |
|
2025-09-28 08:31 |
 |
First Decision by Editorial Office Director |
|
2025-10-10 09:06 |
 |
Return for Revision |
|
2025-10-10 09:06 |
 |
Revised |
|
2025-10-21 09:20 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-01-28 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-01-28 10:36 |
 |
Articles in Press |
|
2026-01-28 10:36 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345